Skip to content
PetriKey

Antimicrobial

Fosfomycin

MurA inhibitor of early cell-wall synthesis

fos-foh-MY-sin

cell-wallmuraurinaryphosphonic-acidbroad-spectrum

High-yield clue

Fosfomycin blocks MurA at the very first step of peptidoglycan synthesis, upstream of the enzymes beta-lactams target.

Overview

A phosphonic-acid antimicrobial studied for irreversibly inhibiting MurA (enolpyruvyl transferase), the first committed step of peptidoglycan synthesis.

Classification

  • Cell-wall synthesis inhibitor
  • Inhibits MurA (UDP-GlcNAc enolpyruvyl transferase)
  • Bactericidal
  • Broad Gram-positive/Gram-negative

Lab & identification clues

  • Earliest-step peptidoglycan inhibition concept
  • Uptake via GlpT / UhpT transporters vocabulary
  • Urinary concentration for single-dose study framing

Associations

  • Lower urinary tract study association
  • Retained activity against many MDR/ESBL organisms
  • Distinct target avoids beta-lactam cross-resistance concept

Commonly confused with

  • Nitrofurantoin
  • Beta-lactams

Frequently asked questions

What is Fosfomycin?

A phosphonic-acid antimicrobial studied for irreversibly inhibiting MurA (enolpyruvyl transferase), the first committed step of peptidoglycan synthesis.

What is the high-yield clue for Fosfomycin?

Fosfomycin blocks MurA at the very first step of peptidoglycan synthesis, upstream of the enzymes beta-lactams target.

What is Fosfomycin associated with?

Fosfomycin is associated with Lower urinary tract study association, Retained activity against many MDR/ESBL organisms, and Distinct target avoids beta-lactam cross-resistance concept.

What is Fosfomycin commonly confused with?

Fosfomycin is commonly confused with Nitrofurantoin and Beta-lactams.

Original mechanism summary for microbiology study. Sources checked: CDC antimicrobial-resistance guidance, NCBI Bookshelf Medical Microbiology, and standard coursework frameworks; reviewed 2026-06. Covers class, mechanism, and resistance vocabulary only; no prescribing, dosing, or patient-specific treatment guidance.

CDC: CDC antimicrobial resistance overview and threat reports - sourceWHO: WHO bacterial priority pathogens list 2024 - sourceNCBI Bookshelf: Medical Microbiology antimicrobial mechanism foundations - source